Cargando…
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma
Aberrant epigenetic reprogramming represents a hallmark of renal cell carcinoma (RCC) tumorigenesis and progression. Whether there existed other epigenetic vulnerabilities that could serve as therapeutic targets remained unclear and promising. Here, we combined the clustered regularly interspaced sh...
Autores principales: | Zhang, Chuanjie, Lu, Xuan, Huang, Jingyi, He, Hongchao, Chen, Li, Liu, Yihan, Wang, Haofei, Xu, Yang, Xing, Siwei, Ruan, Xiaohao, Yang, Xiaoqun, Chen, Lu, Xu, Danfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882098/ https://www.ncbi.nlm.nih.gov/pubmed/33634984 http://dx.doi.org/10.1002/ctm2.328 |
Ejemplares similares
-
Exploration of the cancer genome atlas database reveals genes of interest related with cancer cell stemness indices in clear cell renal cell carcinoma
por: Xing, Siwei, et al.
Publicado: (2022) -
Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma
por: Zhang, Chuanjie, et al.
Publicado: (2021) -
EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation
por: Huang, Hai, et al.
Publicado: (2019) -
Tubulocystic renal cell carcinoma: Two-case report and literature
review
por: Xing, Siwei, et al.
Publicado: (2021) -
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1
por: Zhang, Chuanjie, et al.
Publicado: (2021)